Cargando…
IC(50) Evaluation of Platinum Nanocatalysts for Cancer Treatment in Fibroblast, HeLa, and DU-145 Cell Lines
[Image: see text] Cancer is a major public health problem being one of the main causes of morbidity and mortality today. Recent advances in catalytic nanomedicine have offered new cancer therapies based on the administration of nanoparticles (NPs) of platinum (Pt) dispersed in catalytic mesoporous n...
Autores principales: | González-Larraza, Pamela G., López-Goerne, Tessy M., Padilla-Godínez, Francisco J., González-López, Marco A., Hamdan-Partida, Aida, Gómez, Esteban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542800/ https://www.ncbi.nlm.nih.gov/pubmed/33043218 http://dx.doi.org/10.1021/acsomega.0c03759 |
Ejemplares similares
-
Catalytic Nanomedicine as a Therapeutic Approach to Brain Tumors: Main Hypotheses for Mechanisms of Action
por: López-Goerne, Tessy, et al.
Publicado: (2023) -
Sequence dependence of the hyperthermic potentiation of carboplatin-induced cytotoxicity and intracellular platinum accumulation in HeLa cells.
por: Kusumoto, T., et al.
Publicado: (1993) -
Assessment of action of cis-diamminodichloro-platinum II on HeLa cells by different methods detects time-dependence.
por: Belfield, A., et al.
Publicado: (1982) -
HeLa Cell Transformants Overproducing Mouse Metallothionein Show in vivo Resistance to cis‐Platinum in Nude Mice
por: Toyoda, Haruka, et al.
Publicado: (2000) -
Electrolyte Metabolism in HeLa Cells
por: Wickson-ginzburg, Margaret, et al.
Publicado: (1963)